David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BASE
2101
DELISTED
Couchbase
BASE
| $3.28M | ﹤0.01% |
208,038
+38,920
| +23% | +$645K |
|
2102
Clearfield
CLFD
$406M
| $3.28M | ﹤0.01% |
110,241
+51,781
| +89% | +$1.73M |
|
2103
Pulmonx
LUNG
$107M
| $3.27M | ﹤0.01% |
486,555
+93,719
| +24% | +$664K |
|
|
SEM
2104
DELISTED
Select Medical
SEM
| $3.27M | ﹤0.01% |
196,024
+146,694
| +297% | +$2.7M |
|
|
CMPOW
2105
DELISTED
CompoSecure Inc Warrant
CMPOW
| $3.27M | ﹤0.01% |
843,130
+3,600
| +0.4% | +$15.9K |
|
|
CIVI
2106
CALL
DELISTED
Civitas Resources
CIVI
| $3.27M | ﹤0.01% |
93,700
+59,800
| +176% | +$2.65M |
|
2107
Ouster
OUST
$2.59B
| $3.27M | ﹤0.01% |
363,726
-900,717
| -71% | -$8.89M |
|
2108
United Fire Group
UFCS
$1.39B
| $3.27M | ﹤0.01% |
110,856
+25,217
| +29% | +$681K |
|
|
GAP
2109
The Gap Inc
GAP
$7.61B
| $3.26M | ﹤0.01% |
158,204
+79,379
| +101% | +$1.78M |
|
|
PGAC
2110
Pantages Capital Acquisition Corp
PGAC
| $3.26M | ﹤0.01% |
+325,000
| New | +$3.24M |
|
2111
HNI Corp
HNI
$3.6B
| $3.25M | ﹤0.01% |
+73,313
| New | +$3.47M |
|
2112
American Water Works
AWK
$27.3B
| $3.24M | ﹤0.01% |
+21,983
| New | +$2.9M |
|
2113
Nutrien
NTR
$35.1B
| $3.24M | ﹤0.01% |
65,265
-305,448
| -82% | -$15.6M |
|
2114
BrightView Holdings
BV
$1.02B
| $3.24M | ﹤0.01% |
252,301
+7,964
| +3% | +$114K |
|
|
TBCH
2115
Turtle Beach Corp
TBCH
$229M
| $3.23M | ﹤0.01% |
226,521
-76,656
| -25% | -$1.28M |
|
2116
iShares MSCI Australia ETF
EWA
$1.34B
| $3.22M | ﹤0.01% |
137,321
+97,268
| +243% | +$2.36M |
|
2117
Compass Diversified
CODI
$856M
| $3.22M | ﹤0.01% |
172,343
+122,964
| +249% | +$2.54M |
|
2118
Accuray
ARAY
$31.6M
| $3.21M | ﹤0.01% |
1,793,391
| – | – |
|
|
DX
2119
Dynex Capital
DX
$3.2B
| $3.21M | ﹤0.01% |
+246,546
| New | +$3.3M |
|
2120
Synaptics
SYNA
$3.74B
| $3.21M | ﹤0.01% |
50,315
-146,429
| -74% | -$10.6M |
|
2121
Gold Fields
GFI
$42.6B
| $3.2M | ﹤0.01% |
+145,016
| New | +$2.65M |
|
2122
Ascendis Pharma A/S
ASND
$16.4B
| $3.2M | ﹤0.01% |
20,526
-17,454
| -46% | -$2.49M |
|
2123
CALL
The Mosaic Company
MOS
$7.68B
| $3.2M | ﹤0.01% |
118,400
+100
| +0.1% | +$2.65K |
|
2124
Eastman Chemical
EMN
$8.34B
| $3.2M | ﹤0.01% |
+36,284
| New | +$3.43M |
|
2125
ArcBest
ARCB
$3.11B
| $3.2M | ﹤0.01% |
+45,295
| New | +$3.92M |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $6.08B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.